APRE vs CNP · $10.4M cap vs P/E 26, rev $9.36B
Aprea Therapeutics Inc (APRE) versus CenterPoint Energy Inc (CNP) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
CenterPoint Energy Inc (CNP) is a utilities - regulated electric company listed on NYSE.
APRE does not have a complete income-statement cache yet.
Latest reported CNP revenue for 2025-12-31 was $9.36B. Net income was $1.05B. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
APRE currently screens at market cap $10.4M. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
Not investment advice. Open the APRE and CNP stock pages for the full models.
Not investment advice.